[REVISION HISTORY]
Menopause management & heat coping
Updated 1 time since CLSTR started tracking revisions of this situation.
What changed
2026-07-26 09:10 UTC → 2026-07-31 19:17 UTC ·
added
removed
Menopause management, hormone therapy, management & heat coping
Since April 2026 the ACTG HoT trial has been the first formal study of menopausal hormone therapy (MHT) in women living with HIV. The FemGene® panel began categorising patients into hormone‑response archetypes, and a rapid‑scale telehealth service started compounding personalized bioidentical estradiol and progesterone. Mid‑May research linked self‑pleasure to fewer vasomotor symptoms; a New Hampshire clinic added off‑label bioidentical testosterone pellets for low libido. A meta‑analysis of education programmes showed significant sexual‑function gains, prompting clinicians to pair custom bioidentical formulations with micronutrients such as vitamins B12, D, magnesium, inositol and NAC. June highlighted multidisciplinary sexual‑health care, early symptom tracking and flexible delivery methods (patches, intra‑uterine systems). Parallel studies tied menopause to hair thinning, mucosal dryness, yeast infections and oral‑cavity issues, addressed through TCM, nutrition and preventive counseling. A large US cross‑sectional survey associated current MHT use with healthier diet, exercise and sleep, and market forecasts projected a $24 billion global menopause market by 2030. Heat‑flare guidance emphasized hydration, modest meals, lukewarm showers and limited air‑conditioning. At ENDO 2026, data from 387 postmenopausal women confirmed a 69 % reduction in low bone‑mineral‑density risk with MHT. European observers reported practical heat‑coping tactics—air‑fryers, early‑morning cooking, cooling pillows, well‑ventilated bedrooms—and bedrooms—while a Spanish study highlighted soy isoflavones, flaxseed lignans, omega‑3‑rich fish, water‑rich produce, probiotic dairy, nuts and legumes while urging and urged limits on alcohol, spicy foods, excess caffeine and hot drinks. In July 2026 German gynecologist Katrin Schaudig described neurokinin‑B inhibitors as a newer pharmacologic option for hot flashes, alongside traditional estrogen‑progestogen regimens, phytotherapy and Federal Institute for Public Health lifestyle tips. A July 12 interview reinforced layered clothing, layered, breathable fabrics, hand‑fans clothing. New data from July 2026 show that summer heat waves intensify menopausal and trigger reduction. perimenopausal symptoms by amplifying the stress response and cortisol levels. Italian researchers report that about 80 % of menopausal women experience hot flashes, 60 % night‑time awakenings and 40 % moderate‑to‑severe intensity. A study cited by Italian singer Emma Marrone found perimenopausal women 66 % more likely to have hot flashes in July than in winter, with 75‑80 % reporting vasomotor symptoms overall.
Versions
- 2026-07-31 19:17 UTC Menopause management & heat coping
- 2026-07-26 09:10 UTC Menopause management, hormone therapy, heat coping
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.